Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia

Table 2

Changes of the laboratory data between before treatment and 1 month after partial splenic embolization with transarterial chemoembolization.

	Pretreatment	After 1 week			After 1 month
	Data	Data	Mean of difference	value	Data	Mean of difference	value
Platelet counts (/mm^3)			0.9 (−0.1 to 2.0)	0.083		4.9 (3.2 to 6.7)	<0.001
Hemoglobin (g/dL)			−0.7 (−1.2 to 0.2)	0.012		−0.5 (−1.0 to −0.0)	0.046
Neutrocyte counts (/mm^3)	1,	4,,797	2,241 (1,016 to 3,047)	0.001	2,56,055	687 (408 to 965)	<0.001
Total bilirubin (mg/dL)			0.2 (0.0 to 0.5)	0.063		−0.2 (−0.4 to 0.0)	0.039
Albumin (g/dL)			−0.4 (−0.6 to −0.3)	<0.001		−0.1 (−0.3 to 0.0)	0.036
PT-INR			0.03 (−0.01 to 0.07)	0.123		−0.04 (−0.08 to 0.01)	0.092
Child-Pugh score			0.5 (0.1 to 0.9)	0.021		0.1 (−0.3 to 0.4)	0.748

PT-INR, prothrombin time-international normalized ratio.